These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 19797108)
1. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator for adjuvant therapy in colon cancer. Kumar S; Chang EY; Frankhouse J; Dorsey PB; Lee RG; Johnson N Arch Surg; 2009 Sep; 144(9):835-40. PubMed ID: 19797108 [TBL] [Abstract][Full Text] [Related]
2. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator in colon cancer. Chang EY; Dorsey PB; Frankhouse J; Lee RG; Walts D; Johnson W; Anadiotis G; Johnson N Arch Surg; 2009 Jun; 144(6):511-5. PubMed ID: 19528382 [TBL] [Abstract][Full Text] [Related]
3. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812 [TBL] [Abstract][Full Text] [Related]
4. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022 [TBL] [Abstract][Full Text] [Related]
5. Low microsatellite instability is associated with poor prognosis in stage C colon cancer. Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322 [TBL] [Abstract][Full Text] [Related]
7. Young age influences treatment but not outcome of colon cancer. Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026 [TBL] [Abstract][Full Text] [Related]
9. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131 [TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. Kim GP; Colangelo LH; Wieand HS; Paik S; Kirsch IR; Wolmark N; Allegra CJ; J Clin Oncol; 2007 Mar; 25(7):767-72. PubMed ID: 17228023 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients. Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081 [TBL] [Abstract][Full Text] [Related]
12. [Colon cancer: what is new in 2004?]. André T; Louvet C; de Gramont A Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808 [TBL] [Abstract][Full Text] [Related]
13. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
14. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer. de Weger VA; Turksma AW; Voorham QJ; Euler Z; Bril H; van den Eertwegh AJ; Bloemena E; Pinedo HM; Vermorken JB; van Tinteren H; Meijer GA; Hooijberg E Clin Cancer Res; 2012 Feb; 18(3):882-9. PubMed ID: 22156611 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Elsaleh H; Iacopetta B Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population. Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in sporadic colon cancer with high-level microsatellite instability. Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578 [TBL] [Abstract][Full Text] [Related]
19. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720 [TBL] [Abstract][Full Text] [Related]
20. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]